A Portfolio Review: Unlocking Data Licensing Referral Opportunities

Operating teams regularly conduct portfolio reviews. These sessions can reveal valuable data licensing opportunities for companies within your portfolio, providing a new revenue stream without requiring you to handle any data directly.

How can you find data licensing referral opportunities during a portfolio review?

A portfolio review identifies companies with 50+ peak full-time employees, extensive historical records, existing licensing rights, and an authorized sponsor. Partners only introduce the company to SourceX, never handling or accessing its data.

During a portfolio review, assess companies for key indicators. Look for those with 50 or more full-time employees at their peak, excluding contractors. Identify companies with years of valuable operational records, which could include customer interactions, product usage, or process data. Confirm the company holds the necessary licensing rights for its data. Also, ensure there is an authorized sponsor, typically a C-suite executive, who can approve the data licensing. Your role is solely to make the introduction to SourceX. The company maintains full control over its data; partners never access or manage it.

When should you raise a data licensing introduction during a portfolio review?

Introduce data licensing when a company's authorized sponsor is present and can decide on potential participation. The 90-day attribution window means timing is important, but the company's readiness and approval are paramount.

The ideal time to discuss data licensing is when the company's authorized sponsor—such as a CEO, CFO, or General Counsel—is part of the review and can make a direct decision or commit to exploring the opportunity. This ensures immediate alignment and prevents delays. Keep in mind the 90-day attribution window for referred companies under current terms. This emphasizes the value of timely introductions after confirming the company meets the basic criteria. However, always prioritize the company's readiness and explicit approval before making any introduction.

Who controls the company records during a portfolio review?

The company fully controls its records and must possess the required licensing rights. A portfolio review can clarify which executive has the authority to make decisions regarding data licensing and ownership.

The company always retains complete control over its records and data. It is essential that the company holds the necessary licensing rights for any data it considers sharing. A portfolio review can be instrumental in determining which owner, C-suite executive, or General Counsel has the ultimate authority to approve data licensing initiatives. Partners do not, under any circumstances, take possession of, handle, or manage any company data. Your role is purely facilitative, connecting the company with SourceX, which then handles all data anonymization and licensing processes directly with the company.

Which operating archives should be inventoried during a portfolio review?

During a portfolio review, inventory archives like support tickets, email/chat histories, CRM data, SOPs, and engineering histories. The company controls its data and remains in charge of which archives are considered.

Focus on operational archives that hold rich, structured, or semi-structured data. During a portfolio review, consider discussing:

• Support ticket systems
• Email and chat archives
• Customer Relationship Management (CRM) history
• Standard Operating Procedures (SOPs)
• Engineering histories (e.g., Jira tickets, code change logs)

These archives often contain valuable historical data suitable for licensing. Emphasize that the company retains full control over its data and decides which archives, if any, it wishes to make available. Partners never handle or directly access this data; the company works directly with SourceX for assessment and anonymization.

How should partners explain potential referral earnings during a portfolio review?

Explain rewards as 25% of SourceX's platform fee, capped at $100,000 per company, paid only after a buyer pays SourceX. Avoid promising specific amounts; the payment is conditional.

When discussing potential earnings, clearly state the reward structure: you would receive 25% of the platform fee SourceX collects from a successful data license. This reward is capped at $100,000 in cumulative payments per referred company. Crucially, emphasize that this payment is conditional; it is only made after a buyer selects and pays for the data, and SourceX receives its fee. Do not promise any specific dollar amounts during a portfolio review, as the actual earnings depend on future licensing agreements and payments. The goal is to provide transparency without creating possible expectations.

When should a data referral pause during a portfolio review?

Pause a referral if a company lacks licensing rights, has no authorized sponsor, or fewer than 50 peak employees. Company approval is paramount, and any blockers must be resolved before proceeding.

It is critical to pause a data licensing introduction if any significant blockers are identified during a portfolio review. These include:

• The company does not hold clear licensing rights to its data.
• There is no identified authorized sponsor willing or able to approve the referral.
• The company has fewer than 50 full-time employees at its peak.

Before any introduction is made, the company's explicit approval is essential. Addressing these issues or confirming compliance ensures that any referral made is viable and respects the company's interests and readiness. Do not proceed until all critical blockers are resolved and the company is fully onboard.